DK1686972T3 - Spröjtbart præparat til indgivelse af D-vitaminderivater - Google Patents

Spröjtbart præparat til indgivelse af D-vitaminderivater

Info

Publication number: DK1686972T3
Authority: DK; Denmark
Prior art keywords: vitamin; administration; derivatives; sprayable preparation; sprayable
Prior art date: 2003-11-21

Application number

DK04803732T

Other languages

English (en)

Inventor

Franck Pitre

Laurent Fredon

Claire Mallard

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-21

Filing date

2004-11-17

Publication date

2008-06-30

2003-11-21 Priority claimed from FR0313660A external-priority patent/FR2862540B1/fr

2004-11-17 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2008-06-30 Application granted granted Critical

2008-06-30 Publication of DK1686972T3 publication Critical patent/DK1686972T3/da

Links

150000003710 vitamin D derivatives Chemical class 0.000 title 1
GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract 1
229960005084 calcitriol Drugs 0.000 abstract 1
235000020964 calcitriol Nutrition 0.000 abstract 1
239000011612 calcitriol Substances 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229920001296 polysiloxane Polymers 0.000 abstract 1
239000007921 spray Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Oil, Petroleum & Natural Gas (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK04803732T 2003-11-21 2004-11-17 Spröjtbart præparat til indgivelse af D-vitaminderivater DK1686972T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0313660A FR2862540B1 (fr)	2003-11-21	2003-11-21	Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US54124504P	2004-02-04	2004-02-04
PCT/EP2004/014085 WO2005053666A1 (en)	2003-11-21	2004-11-17	Sprayable composition for the administration of vitamin d derivatives

Publications (1)

Publication Number	Publication Date
DK1686972T3 true DK1686972T3 (da)	2008-06-30

Family

ID=34655190

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04803732T DK1686972T3 (da)	2003-11-21	2004-11-17	Spröjtbart præparat til indgivelse af D-vitaminderivater

Country Status (15)

Country	Link
EP (2)	EP1952808A3 (da)
JP (1)	JP2007511578A (da)
AT (1)	ATE388697T1 (da)
AU (1)	AU2004294728A1 (da)
BR (1)	BRPI0416311A (da)
CA (1)	CA2543577A1 (da)
CY (1)	CY1107942T1 (da)
DE (1)	DE602004012440T2 (da)
DK (1)	DK1686972T3 (da)
ES (1)	ES2302060T3 (da)
MX (1)	MXPA06005587A (da)
PL (1)	PL1686972T3 (da)
PT (1)	PT1686972E (da)
RU (1)	RU2006121973A (da)
WO (1)	WO2005053666A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1487416E (pt)	2002-03-26	2010-01-25	Teva Pharma	Micropartículas de fármacos
FR2867682B1 (fr) *	2004-03-22	2009-06-05	Galderma Res & Dev	Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
CA2610755A1 (en) *	2005-06-10	2006-12-14	Galderma S.A.	Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
FR2887150B1 (fr) *	2005-06-17	2007-08-03	Galderma Res & Dev	Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2893845B1 (fr) *	2005-11-30	2010-10-29	Galderma Sa	Composition sous forme de spray comprenant un corticoide et une phase huileuse
RU2008142388A (ru) *	2006-04-03	2010-05-10	Тева Фармасьютикл Индастриес Лтд. (Il)	Микрочастицы лекарственного вещества
US10265265B2 (en)	2007-03-15	2019-04-23	Drug Delivery Solutions Limited	Topical composition
EP2008651A1 (en)	2007-06-26	2008-12-31	Drug Delivery Solutions Limited	A bioerodible patch
HUP0900072A2 (hu)	2009-02-06	2010-09-28	Egis Gyogyszergyar Nyilvanosan	Transzdermális gyógyszerkészítmények
US20090175810A1 (en)	2008-01-03	2009-07-09	Gareth Winckle	Compositions and methods for treating diseases of the nail
MX366076B (es)	2009-08-14	2019-06-27	Berg Llc	Vitamina d3 y analogos de la misma para tratar alopecia.
US8039494B1 (en)	2010-07-08	2011-10-18	Dow Pharmaceutical Sciences, Inc.	Compositions and methods for treating diseases of the nail
US9610245B2 (en)	2011-03-14	2017-04-04	Drug Delivery Solutions Limited	Ophthalmic composition
SG10201709894RA (en) *	2013-05-29	2018-01-30	Berg Llc	Preventing or mitigating chemotherapy induced alopecia using vitamin d
MX363386B (es)	2013-10-03	2019-03-20	Dow Pharmaceutical Sciences	Formulaciones de efinaconazol estabilizadas.
KR102612453B1 (ko)	2013-11-22	2023-12-08	다우 파마슈티컬 사이언시즈, 인코포레이티드	항감염 방법，조성물，및 장치
WO2017102792A1 (en) *	2015-12-18	2017-06-22	Dsm Ip Assets B.V.	Biaromatic vitamin d analogs
EP3389607B1 (en) *	2015-12-18	2020-07-15	DSM IP Assets B.V.	Biaromatic vitamin d analogs
US10336675B2 (en)	2015-12-18	2019-07-02	Dsm Ip Assets B.V.	Biaromatic vitamin D analogs
CN108366941B (zh)	2015-12-18	2021-06-18	帝斯曼知识产权资产管理有限公司	新颖的化合物
EP3542788A1 (en)	2018-03-19	2019-09-25	MC2 Therapeutics Limited	Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4678663A (en) *	1984-02-06	1987-07-07	Nuetrogena Corporation	Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4525341A (en) *	1984-04-09	1985-06-25	Mayor Pharmaceutical Laboratories, Inc.	Method of administering vitamins
FI872553L (fi) *	1986-06-09	1987-12-10	American Cyanamid Co	Medium foer laekemedel foer lokalt bruk.
US4889845A (en) *	1986-06-09	1989-12-26	American Cyanamid Company	Vehicle for topical application of pharmaceuticals
JPH02145512A (ja) *	1988-11-26	1990-06-05	Shin Etsu Chem Co Ltd	被膜形成型外用剤
GB9109733D0 (en) *	1991-05-07	1991-06-26	Unilever Plc	Cosmetic composition
FR2719220A1 (fr) *	1994-04-29	1995-11-03	Lafon Labor	Nouvelle forme galénique pour l'administration transdermique.
US6538039B2 (en) *	1994-04-29	2003-03-25	Laboratoire L. Lafon	Pharmaceutical dosage form for transdermal administration
FR2740038B1 (fr) *	1995-10-20	1998-01-02	Lafon Labor	Composition pour l'administration transdermique
FR2753626B1 (fr)	1996-09-20	1998-11-06	Centre International De Rech Dermatologiques Galderma Cird Galderma	Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
FR2760971B1 (fr) *	1997-03-20	1999-12-10	Dow Corning Sa	Procede de production d'une composition a liberation controlee
GB9902812D0 (en) *	1998-06-18	1999-03-31	Dow Corning Sa	Composition for delivering pharmaceutically active agents
EP0966972B1 (en) *	1998-06-18	2003-09-24	Dow Corning France S.A.	Topical composition containing silicon gum
FR2785284B1 (fr) *	1998-11-02	2000-12-01	Galderma Res & Dev	Analogues de la vitamine d
FR2801307B1 (fr)	1999-11-24	2002-12-06	Galderma Res & Dev	Analogues de la vitamine d
FR2801305B1 (fr)	1999-11-24	2002-12-06	Galderma Res & Dev	Analogues de la vitamine d
FR2825087B1 (fr)	2001-05-22	2005-01-14	Galderma Res & Dev	Analogues de la vitamine d
FR2833258B1 (fr)	2001-12-10	2004-08-27	Galderma Res & Dev	Analogues de la vitamine d
US7655717B2 (en) *	2002-07-17	2010-02-02	Mary J. Goulbourne	Ointment composition for treating decubitus ulcers and methods for its making and its use
WO2004069134A2 (en) *	2003-02-05	2004-08-19	Galderma Research & Development, S.N.C.	Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology

2004
- 2004-11-17 DK DK04803732T patent/DK1686972T3/da active
- 2004-11-17 RU RU2006121973/15A patent/RU2006121973A/ru unknown
- 2004-11-17 AU AU2004294728A patent/AU2004294728A1/en not_active Abandoned
- 2004-11-17 CA CA002543577A patent/CA2543577A1/en not_active Abandoned
- 2004-11-17 EP EP08100323A patent/EP1952808A3/en not_active Withdrawn
- 2004-11-17 WO PCT/EP2004/014085 patent/WO2005053666A1/en not_active Ceased
- 2004-11-17 MX MXPA06005587A patent/MXPA06005587A/es active IP Right Grant
- 2004-11-17 AT AT04803732T patent/ATE388697T1/de active
- 2004-11-17 JP JP2006540412A patent/JP2007511578A/ja active Pending
- 2004-11-17 DE DE602004012440T patent/DE602004012440T2/de not_active Expired - Lifetime
- 2004-11-17 EP EP04803732A patent/EP1686972B1/en not_active Expired - Lifetime
- 2004-11-17 BR BRPI0416311-7A patent/BRPI0416311A/pt not_active IP Right Cessation
- 2004-11-17 PL PL04803732T patent/PL1686972T3/pl unknown
- 2004-11-17 PT PT04803732T patent/PT1686972E/pt unknown
- 2004-11-17 ES ES04803732T patent/ES2302060T3/es not_active Expired - Lifetime
2008
- 2008-05-13 CY CY20081100500T patent/CY1107942T1/el unknown

Also Published As

Publication number	Publication date
RU2006121973A (ru)	2007-12-27
EP1952808A2 (en)	2008-08-06
WO2005053666A1 (en)	2005-06-16
BRPI0416311A (pt)	2006-12-26
MXPA06005587A (es)	2006-08-11
AU2004294728A1 (en)	2005-06-16
CY1107942T1 (el)	2013-09-04
ATE388697T1 (de)	2008-03-15
PT1686972E (pt)	2008-04-23
DE602004012440T2 (de)	2009-03-26
PL1686972T3 (pl)	2008-09-30
CA2543577A1 (en)	2005-06-16
EP1686972A1 (en)	2006-08-09
EP1952808A3 (en)	2008-09-03
DE602004012440D1 (de)	2008-04-24
EP1686972B1 (en)	2008-03-12
ES2302060T3 (es)	2008-07-01
JP2007511578A (ja)	2007-05-10

Publication	Publication Date	Title
CY1107942T1 (el)	2013-09-04	Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d
MXPA05013232A (es)	2006-03-09	Composicion en forma de pulverizador que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa no volatil.
ITMI20031570A1 (it)	2005-02-01	Composizione per uso dietetico, farmaceutico o cosmetico
CY1107033T1 (el)	2012-09-26	Συνθεση στη μορφη σπρεϊ η οποια περιλαμβανει ενα συνδυασμο προπιονικης κλομπεταζολης και καλσιτριολης, μια αλκοολικη φαση και μια ελαιωδη φαση
AR046642A1 (es)	2005-12-14	Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
DK1521573T3 (da)	2008-03-25	Ikke-polymere, lipofile, farmaceutiske implantatsammensætninger til intrakulær anvendelse
ATE535239T1 (de)	2011-12-15	Formulierungen enthaltend amiodaron und sulfoalkylethercyclodextrin
PA8570901A1 (es)	2003-11-12	Derivados de acil-4-carboxifenilurea, procedimientos para su preparacion y su uso
WO2004066918A3 (en)	2005-04-28	Long wear cosmetic composition
IS8398A (is)	2006-04-05	Lyfjasamsetningar til að meðhöndla æxli
EA200701065A1 (ru)	2007-12-28	Инъецируемые составы, содержащие нанодисперсный оланзапин
CL2004000889A1 (es)	2005-03-18	COMPUESTOS DERIVADOS DE PIRAZOLO[4,3-d]PIRIMIDINA; COMPUESTOS INTERMEDIARIOS; COMPOSICION FARMACEUTICA; PROCEDIMIENTO DE PREPARACION Y SU USO EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA HIPERTENSION.
DK1797053T3 (da)	2011-02-21	Phenothiazinium-forbindelse til sårheling
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
MY156471A (en)	2016-02-26	Combination of lycopene, polyphenol and vitamins for the care of keratin material
ITRM20030363A0 (it)	2003-07-24	Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
ITMI20031396A1 (it)	2005-01-10	Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
BRPI0516464A (pt)	2008-09-09	formulação farmacêutica, método para a preparação de um produto farmacêutico, e, uso de uma formulação farmacêutica
DK1771180T4 (da)	2011-04-11	Sammensætning i form af en spray, der omfatter en kombination af clobetasolpropionat og calcitriol, en alkoholfase og en oliefase
BRPI0810960A2 (pt)	2015-01-27	"composto, composição farmacêutica, composição cosmética e usos de um composto e de uma composição".
AR028122A1 (es)	2003-04-23	Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones
ITRM20020119A1 (it)	2003-09-05	Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
WO2005051353A3 (en)	2005-10-27	Pharmaceutical formulations comprising voriconazole
WO2008129189A3 (fr)	2009-01-22	Nouveaux composés carbamates de vitamine c, compositions les comprenant, et utilisations
IT1317818B1 (it)	2003-07-15	Procedimento per la produzione di componenti per integratorialimentari, formulazioni dietetiche, cosmetiche e farmaceutiche,